1 completed, 1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Off Episodes of Parkinson Disease: new trials by email Literature Review of Off Episodes of Parkinson Disease trials Research Report on Off Episodes of Parkinson Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-world Patient Experiences With Inbrija® Levodopa inhalation powder - Parkinson Disease (PD), Parkinson's Disease | Recruiting | Merz Therapeutics GmbH | 120 | 2026-09-01 | 2026-10-02 | |
| A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes APL-130277, Placebo, Moxifloxacin - Parkinson's Disease, Off Episodes of Parkinson Disease | Phase 2 | Completed | Sumitomo Pharma America, Inc. | 48 | 2017-08-03 | 2020-08-10 |
Parkinson Disease (2) · Fatigue (1) · Social Stigma (1)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Parkinsonian Disorders (2) · Synucleinopathies (2) · Behavior (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Social Behavior (1)
Apomorphine (1) · Dihydroxyphenylalanine (1) · Moxifloxacin (1)
Merz Therapeutics GmbH (1) · Sumitomo Pharma America, Inc. (1)
Austria (1) · Italy (1) · United States (1)
2016 (1)